logo
  

Munich Re Preliminary Q3 Result Better Than Consensus; Affirms Guidance - Quick Facts

Munich Re (0KFE.L) said the company achieved a preliminary result of around 0.4 billion euros in third quarter of 2021. This is compared to consensus or, an average of estimates from 15 financial analysts, which was negative at 10 million euros.

The company said the result was due to continued positive performance in all segments and a high investment result - also due in part to large gains on disposals - as well as a high currency translation result. The result was burdened by high losses from natural catastrophes during the period.

For the first nine months, Munich Re recorded a result of roughly 2.1 billion euros. For the full year 2021, the company expects it will still meet overall profit target of 2.8 billion euros.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
This Black Friday and the following holiday season, retailers across the United States are urged to keep up their inventory amid expected surge in shopping as majority of Americans wait till last minute to fill their baskets, according to certain studies. A new Oracle Retail survey, which was conducted last week and presented earlier this week, showed that 66 percent of consumers were less than Eagle, Idaho -based Flagship Food Group is recalling certain TJ Farms Select brand frozen cauliflower, citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The recall involves a limited number of cases of TJ Farms Select cauliflower that comes in 16 oz. packages with lot code 2077890089 and UPC code 75544000604-3. The U.S. Food and Drug Administration has approved Takeda Pharmaceuticals Co. Ltd.'s Livtencity (maribavir) as the first drug to treat post-transplant cytomegalovirus or CMV in adults and pediatric patients. The approval is to treat patients 12 years of age and older and weighing at least 35 kilograms with post-transplant CMV infection/disease that does not respond...
Follow RTT